Glucagon-like peptide-1 analogues for overweight or obese adults

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

To assess the effects of glucagon-like peptide-1 analogues on overweight or obese adults.

This is a protocol.

Published:

8 September 2022

Authors:

Madrid E, Ocara Vargas M, Contreras-Vera C, Saldías C, Escobar Liquitay CM, Novik A V, Munoz SR, Bracchiglione J

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Madrid E, Ocara Vargas M, Contreras-Vera C, Saldías C, Escobar Liquitay CM, Novik A V, Munoz SR, Bracchiglione J. Glucagon-like peptide-1 analogues for overweight or obese adults (Protocol). Cochrane Database of Systematic Reviews 2022, Issue 9. Art. No.: CD015092. DOI: 10.1002/14651858.CD015092.